Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple metabolic and matrix-related pathways" refers to a broad set of biological processes rather than a single, discrete molecular target such as a receptor or enzyme. Metabolic pathways encompass the vast network of chemical reactions responsible for energy production and biosynthesis (Kanehisa et al., 2023), while matrix-related pathways govern the assembly, remodeling, and degradation of the extracellular matrix (Gillespie et al., 2022). These pathways are often dysregulated in complex conditions like organ fibrosis, metabolic syndrome, and oncology, where metabolic shifts support pathological cell behavior and matrix changes alter tissue architecture (NCBI Bookshelf, 2021). Because this designation covers a wide array of distinct proteins and signaling cascades, it is considered an "incorrect" target for drug discovery. Therapeutic intervention typically requires identifying and modulating specific individual components within these pathways to achieve selectivity and minimize off-target effects (Nature Reviews Drug Discovery, 2020).
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple metabolic and matrix-related pathways.